Finance

Lists
Why is 301206 up 2,05%?
Dive Deeper
301206:SHE
Shandong Sanyuan Biotechnology Co Ltd
CN¥24,92
+2,05%
(+0,50) 1D
16 Okt., 12:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301206...
Open
CN¥24,75
High
CN¥25,25
Low
CN¥24,54
Mkt. cap
5,05 mjd
Avg. vol.
4,81 m
Volume
1,42 m
P/E ratio
59,47
52-wk high
CN¥30,48
52-wk low
CN¥21,81
EPS
CN¥0,42
Shares outstanding
202,33 m
No. of employees
441
Open
CN¥24,75
High
CN¥25,25
Low
CN¥24,54
Mkt. cap
5,05 mjd
Avg. vol.
4,81 m
Volume
1,42 m
P/E ratio
59,47
52-wk high
CN¥30,48
52-wk low
CN¥21,81
EPS
CN¥0,42
Shares outstanding
202,33 m
No. of employees
441
News stories
From web sources and news partners
About Shandong Sanyuan Biotechnology Co Ltd
CEO-
Employees441
Founded26 Jan. 2007
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
158,11 m
173,43 m
224,78 m
203,93 m
Cost of goods sold
141,47 m
147,64 m
187,32 m
168,41 m
Cost of revenue
141,47 m
147,64 m
187,32 m
168,41 m
Research and development expenses
10,01 m
9,62 m
8,24 m
10,45 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,54 m
6,84 m
10,17 m
8,37 m
Operating expense
21,09 m
17,42 m
18,59 m
20,53 m
Total operating expenses
162,55 m
165,06 m
205,92 m
188,94 m
Operating income
-4,44 m
8,38 m
18,86 m
14,99 m
Other non operating income
-51,93 k
-68,24 k
-3,14 m
3,00 m
EBT including unusual items
11,15 m
27,66 m
29,45 m
28,05 m
EBT excluding unusual items
11,08 m
26,30 m
27,62 m
27,06 m
Income tax expense
1,24 m
3,65 m
3,36 m
3,75 m
Effective tax rate
11,09%
13,18%
11,40%
13,35%
Other operating expenses
773,97 k
1,06 m
386,74 k
1,80 m
Net income
9,92 m
24,01 m
26,09 m
24,31 m
Net profit margin
6,27%
13,84%
11,61%
11,92%
Earnings per share
-
-
-
-
Interest and investment income
16,79 m
19,38 m
11,90 m
14,24 m
Interest expense
-
-
-
-
Net interest expenses
16,79 m
19,38 m
11,90 m
14,24 m
Depreciation and amortization charges
-
-
-
-
EBITDA
12,11 m
26,75 m
37,24 m
36,18 m
Gain or loss from assets sale
-36,37 k
-65,75 k
-
-
AI content may include mistakes. Learn more
Google-programme